Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  glycosylated recombinant human G-CSF AVI-014
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Blinatumomab and T Cell Depleted Donor Blood Cell Transplant in Treating Younger Patients with Relapsed or Refractory Hematologic Malignancy after a Previous Transplant
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 21 and under
Trial IDs: REF2HCT, NCI-2016-00812, NCT02790515
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients with Secondary Myelofibrosis
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 to 75
Trial IDs: 16420, NCI-2017-00613, NCT03118492
Start Over